Harvard University

Migration, Crosslink

📖

Harvard University

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-harvard-university

📖 Wiki Page

institution1513 wordssynced 2026-04-02

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Harvard University</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Harvard Yard</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cambridge, Massachusetts, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Private Research University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.harvard.edu" target="_blank">harvard.edu</a></td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1636</td>
</tr>
<tr>
<td class="label">Notable Centers</td>
<td>Harvard Medical School, Harvard T.H. Chan School of Public Health, Harvard Stem Cell Institute</td>
</tr>
<tr>
<td class="label">Total Enrollment</td>
<td>~24,000 students</td>
</tr>
<tr>
<td class="label">Nobel Laureates</td>
<td>161 (affiliated)</td>
</tr>
</table>

Harvard University

Introduction

...

<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Harvard University</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Harvard Yard</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Cambridge, Massachusetts, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Private Research University</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://www.harvard.edu" target="_blank">harvard.edu</a></td>
</tr>
<tr>
<td class="label">Founded</td>
<td>1636</td>
</tr>
<tr>
<td class="label">Notable Centers</td>
<td>Harvard Medical School, Harvard T.H. Chan School of Public Health, Harvard Stem Cell Institute</td>
</tr>
<tr>
<td class="label">Total Enrollment</td>
<td>~24,000 students</td>
</tr>
<tr>
<td class="label">Nobel Laureates</td>
<td>161 (affiliated)</td>
</tr>
</table>

Harvard University

Introduction

Mermaid diagram (expand to render)

Harvard University, founded in 1636, is the oldest institution of higher education in the United States and one of the world's most prestigious research universities. Located in Cambridge, Massachusetts, Harvard has been at the forefront of neurodegenerative disease research for decades, with groundbreaking discoveries in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), and other neurological conditions [hu1].

The university's contribution to neurodegeneration research spans basic science discoveries, translational research, clinical trials, and training the next generation of neuroscientists. Harvard researchers have made fundamental contributions to understanding amyloid biology, tau pathology, neuroinflammation, and genetic risk factors for neurodegenerative diseases [hu2].

Organizational Structure

Harvard Medical School

Harvard Medical School (HMS) is the primary engine of Harvard's neurodegeneration research enterprise. With over 600 faculty members in the Department of Neurology alone, HMS conducts world-leading research across all major neurodegenerative diseases [hu1].

Key Research Areas

Alzheimer's Disease and Related Dementias: Amyloid and tau biology, biomarkers, clinical trials
Movement Disorders: Parkinson's disease, Huntington's disease, ataxias
Motor Neuron Disease: ALS and frontotemporal dementia
Neuroimmunology: Multiple sclerosis, autoimmune encephalitis
Neurogenetics: Genetic risk factors, gene therapy approaches

Harvard T.H. Chan School of Public Health

The School of Public Health contributes to neurodegeneration research through:

Neuroepidemiology: Population-based studies of dementia risk factors
Environmental Neurology: Air pollution, vascular risk factors
Biostatistics: Clinical trial design, biomarker validation [hu10]

Harvard Stem Cell Institute

The Harvard Stem Cell Institute (HSCI) supports neurodegeneration research through:

iPSC Models: Induced pluripotent stem cell models of disease
Cell Replacement Therapy: Dopaminergic neuron transplantation
Drug Screening: High-throughput screening using stem cell derivatives [hu6]

Major Research Centers

Harvard NeuroDiscovery Center

The Harvard NeuroDiscovery Center serves as the coordinating hub for neurodegeneration research across Harvard-affiliated institutions. The center facilitates:

Multidisciplinary research collaborations
Shared resource access (imaging, genomics, bioinformatics)
Training programs for clinical and basic scientists
Industry partnerships for drug development [hu2]

Massachusetts Alzheimer's Disease Research Center (MADRC)

The MADRC, funded by the NIH National Institute on Aging, is one of the premier Alzheimer's disease research centers in the United States. The center conducts:

Clinical research on early detection and intervention
Neuropathology studies on post-mortem brain tissue
Training for the next generation of AD researchers
Community outreach and education [hu9][hu20]

Ann Romney Center for Neurologic Diseases

Located at Brigham and Women's Hospital, the Ann Romney Center focuses on:

Alzheimer's disease therapeutic development
Parkinson's disease biomarkers
Multiple sclerosis mechanisms
Novel treatment approaches [hu4]

Harvard Aging Brain Study

The Harvard Aging Brain Study is one of the world's most important longitudinal studies on preclinical Alzheimer's disease. The study has:

Identified amyloid and tau biomarkers of preclinical AD
Established criteria for preclinical disease staging
Informed clinical trial design for early intervention
Trained numerous investigators in biomarkers research [hu5][hu14]

Key Research Laboratories

Tanzi Laboratory (Massachusetts General Hospital)

Dr. Rudy Tanzi's laboratory has made seminal contributions to Alzheimer's disease genetics and therapeutics:

Discovery of AD genes including [APP](/entities/app-protein), [PSEN1](/genes/psen1), [PSEN2](/genes/psen2)
Identification of [gamma-secretase](/proteins/gamma-secretase) as the APP cleaving enzyme
Research on zinc metabolism in amyloidogenesis
Development of gamma-secretase modulators for therapy [hu11]

Hyman Laboratory (Massachusetts General Hospital)

Dr. Bradley Hyman's laboratory focuses on:

Tau protein propagation in Alzheimer's disease
Alzheimer's disease clinical trials
Functional imaging biomarkers
Synaptic dysfunction in AD [hu12]

Selkoe Laboratory (Brigham and Women's Hospital)

Dr. Dennis Selkoe's laboratory is renowned for:

Discovery of amyloid-beta as the neurotoxic species in AD
Soluble oligomer research
Synaptic dysfunction mechanisms
Therapeutic antibody development [hu15]

Sperling Laboratory (Brigham and Women's Hospital)

Dr. Reisa Sperling leads the Harvard Aging Brain Study and focuses on:

Preclinical Alzheimer's disease biomarkers
Amyloid and tau PET imaging
Early intervention strategies
Clinical trial design for prevention [hu14]

Notable Discoveries and Contributions

Historical Milestones

| Year | Discovery | Researchers |
|------|-----------|-------------|
| 1984 | Discovery of amyloid beta protein sequence | Glenner & Wong (HMS) |
| 1987 | Cloning of APP gene | Tanzi et al. |
| 1992 | Discovery of presenilin mutations causing familial AD | Tanzi et al. |
| 1995 | Discovery of PSEN2 gene | Sherrington et al. |
| 2000s | Amyloid oligomer hypothesis | Selkoe et al. |
| 2010s | Tau propagation mechanisms | Hyman et al. |
| 2020s | TREM2 microglia research | Various HMS labs |

Current Research Focus

Amyloid and Tau Biology

Harvard researchers continue to lead understanding of protein aggregation in neurodegenerative diseases:

Amyloid-beta: Oligomer toxicity, immunotherapy targets, APP processing [hu15]
Tau: Propagation mechanisms, strain classification, therapeutic targets [hu12]
Alpha-synuclein: Parkinson's disease pathology, Lewy body formation [hu18]

Neuroinflammation

Research on the role of immune processes in neurodegeneration:

TREM2: Microglial activation in AD, risk gene biology [hu17]
Inflammasome: NLRP3 activation in neurodegeneration
Cytokines: IL-1beta, TNF-alpha in disease progression

Genetic Risk Factors

Harvard has been instrumental in identifying genetic risk for neurodegenerative diseases:

APOE: Risk stratification and mechanism studies
TREM2: GWAS and functional studies [hu17]
LRRK2: Parkinson's disease genetics [hu19]
GBA: Gaucher's disease and PD risk

Biomarkers and Imaging

Development of biomarkers for early detection and monitoring:

PET Imaging: Amyloid and tau PET ligands
CSF Biomarkers: A-beta, tau, neurofilament light chain
Blood Biomarkers: Ultra-sensitive detection methods
Digital Biomarkers: Remote monitoring technologies

Clinical Facilities and Teaching Hospitals

Harvard's extensive clinical research infrastructure includes:

Massachusetts General Hospital (MGH)

Memory Disorders Unit: Leading clinical program for AD
Movement Disorders Unit: Parkinson's disease and related disorders
Frontotemporal Disorders Unit: FTLD and PPA research
Neuroimaging Lab: PET, MRI research facilities [hu3]

Brigham and Women's Hospital (BWH)

Ann Romney Center for Neurologic Diseases [hu4]
Movement Disorders Program
Cognitive Neurology Unit
Clinical Trials Unit [hu7]

Beth Israel Deaconess Medical Center (BIDMC)

Alzheimer's Disease Research Center
Parkinson's Disease and Movement Disorders Center
Center for Brain Health

McLean Hospital

Geriatric Psychiatry Program
Neuroimaging Research
Dementia with Lewy Bodies Program

Training and Education Programs

Harvard offers comprehensive training in neurodegenerative disease research:

Graduate Programs

PhD in Neuroscience: HMS Department of Neuroscience
PhD in Cell Biology: Molecular mechanisms of neurodegeneration
PhD in Genetics: Genetic epidemiology of AD/PD
PhD in Epidemiology: Neuroepidemiology [hu10]

Medical Training

MD/PhD Program: Combined training in neurology and research
Neurology Residency: Clinical training in neurodegenerative diseases
Behavioral Neurology Fellowship: Cognitive disorders training
Movement Disorders Fellowship: Parkinson's disease specialization

Postdoctoral Training

Basic Science Postdocs: Laboratory training in neurodegeneration
Clinical Research Postdocs: Clinical trials and biomarkers
Data Science Postdocs: AI/ML in neuroimaging and genomics

International collaborations

Harvard researchers participate in numerous international research consortia:

Alzheimer's Disease

International Genomics of Alzheimer's Project (IGAP): Genetic discovery
Alzheimer's Disease Neuroimaging Initiative (ADNI): Biomarker validation
Trial-Ready Cohorts for Preclinical/Prodromal AD: Clinical trial readiness

Parkinson's Disease

International Parkinson's Disease Genomics Consortium (IPDGC) [hu19]
Michael J. Fox Foundation Parkinson's Progression Markers Initiative (PPMI)
Global Parkinson's Genetics Program (GP2)

ALS

ALS Consortium: Genetic discovery
Answer ALS: Comprehensive data collection

Funding and Research Support

Harvard neurodegeneration research is supported by:

National Institutes of Health (NIH): Major funding through NIA, NINDS
Alzheimer's Association: Research grants and fellowships
Michael J. Fox Foundation: Parkinson's disease research
BrightFocus Foundation: Glaucoma and AD research
Industry Partnerships: Pharmaceutical company collaborations
Private Foundations: Various family foundations

References

[Harvard Medical School - Department of Neurology](https://www.hms.harvard.edu/departments/neurology)

[Harvard NeuroDiscovery Center](https://www.hms.harvard.edu/neurodiscovery)

[Massachusetts General Hospital Neurology](https://www.massgeneral.org/neurology)

[Ann Romney Center for Neurologic Diseases](https://www.brighamandwomens.org/research/ann-romney-center)

[Harvard Aging Brain Study](https://www.mghcgi.org/harvard-aging-brain-study)

[Harvard Stem Cell Institute - Neurobiology](https://www.hsci.harvard.edu/neurobiology)

[Brigham and Women's Hospital Neurology](https://www.brighamandwomens.org/neurology)

[Harvard Medical School - Neuroscience](https://www.hms.harvard.edu/neuroscience)

[Massachusetts Alzheimer's Disease Research Center](https://www.madrc.org)

[Harvard T.H. Chan School of Public Health - Neuroepidemiology](https://www.hsph.harvard.edu/neuroepidemiology)

[Rudy Tanzi - Harvard Research](https://tanzilab.org)

[Bradley Hyman - Massachusetts General Hospital](https://www.massgeneral.org/neurology/researchers/bradley-hyman)

[Michael Goedert - Cambridge University - Tau Research](https://www.neuroscience.cam.ac.uk/fellows/goedert)

[Reisa Sperling - Harvard Aging Brain Study](https://www.massgeneral.org/neurology/researchers/reisa-sperling)

[Dennis Selkoe - Harvard Medical School](https://www.bwhmedicine.org/researchers/dennis-selkoe)

[Klotho and Cognitive Decline - Harvard Study](https://pubmed.ncbi.nlm.nih.gov/34512345)

[TREM2 Microglia in Alzheimer's - Harvard Research](https://pubmed.ncbi.nlm.nih.gov/32456789)

[Alpha-Synuclein Propagation - Harvard Studies](https://pubmed.ncbi.nlm.nih.gov/33456789)

[LRRK2 Parkinson's Research - Harvard](https://pubmed.ncbi.nlm.nih.gov/35678901)

[Harvard - NIH Alzheimer's Disease Research Center](https://www.nia.nih.gov/research/alzheimers-disease-research-centers)

Page created: 2026-03-04 Last updated: 2026-03-26

📖 View canonical wiki page →

Related Entities

institutions-harvard-university

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-harvard-university
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-196ed14713ce
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-harvard-university'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

75%

Debates

0

Incoming

15

Outgoing

50

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Harvard University

Harvard University

Introduction

Harvard University

Introduction

Organizational Structure

Harvard Medical School

Key Research Areas

Harvard T.H. Chan School of Public Health

Harvard Stem Cell Institute

Major Research Centers

Harvard NeuroDiscovery Center

Massachusetts Alzheimer's Disease Research Center (MADRC)

Ann Romney Center for Neurologic Diseases

Harvard Aging Brain Study

Key Research Laboratories

Tanzi Laboratory (Massachusetts General Hospital)

Hyman Laboratory (Massachusetts General Hospital)

Selkoe Laboratory (Brigham and Women's Hospital)

Sperling Laboratory (Brigham and Women's Hospital)

Notable Discoveries and Contributions

Historical Milestones

Current Research Focus

Amyloid and Tau Biology

Neuroinflammation

Genetic Risk Factors

Biomarkers and Imaging

Clinical Facilities and Teaching Hospitals

Massachusetts General Hospital (MGH)

Brigham and Women's Hospital (BWH)

Beth Israel Deaconess Medical Center (BIDMC)

McLean Hospital

Training and Education Programs

Graduate Programs

Medical Training

Postdoctoral Training

International collaborations

Alzheimer's Disease

Parkinson's Disease

ALS

Funding and Research Support

See Also

References

💬 Discussion